Assistant Professor, Internal Medicine, University of Missouri, Columbia School of Medicine
Nephrology
Dr. Ravi Nistala, MD
|
|
Give Review
Doctor Ravi Nistala, MD practices Nephrology. He went to Grant Medical College. He over the years received 1 awards: "Meaningful Use Stage 1 Certification". Ravi Nistala is a published MD. He published 37 publications, including: 'Mineralocorticoid Receptor Blockade Prevents Western Diet-induced Diastolic Dysfunction in Female Mice.' Doctor Ravi Nistala, MD accepts all Medicare patients.
Publications
- Mineralocorticoid Receptor Blockade Prevents Western Diet-induced Diastolic Dysfunction in Female Mice.
- Dipeptidyl peptidase-4 inhibition ameliorates western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic ...
- DPP4 Inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat.
- Tissue-Specific Expression of GLP1R in Mice: Is the Problem of Antibody Nonspecificity Solved?
- Is there a role for the incretin system in blood pressure regulation?
- Dipeptidylpeptidase Inhibition is Associated With Improvement in Blood Pressure and Diastolic Function in Insulin Resistant Male Zucker Obese Rats.
- Resistance to Insulin and Kidney Disease in the CardioRenal Metabolic Syndrome; role for Angiotensin II.
- Angiotensin Type 1 Receptor Resistance To Blockade In The Opossum Proximal Tubule Cell Due To Variations In The Binding Pocket.
- Hypertension: Synergy of antihypertensives in elderly patients With CKD.
- Gestational Diabetes and the Offspring: Implications in the Development of the CardioRenal Metabolic Syndrome in Offspring.
- Anemia and Chronic Kidney Disease: Making Sense of the Recent Trials.
- Combination of direct renin inhibition with angiotensin type 1 receptor blockade improves aldosterone but does not improve Kidney injury in the transgenic Ren2 rat.
- A reliable and efficient method for deleting operational sequences in PACs and BACs.
- Differential expression of the closely linked KISS1, REN, and FLJ10761 genes in transgenic mice.
- Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells.
- Skeletal muscle insulin resistance is fundamental to the cardiometabolic syndrome.
- Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury.
- Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling With statin treatment.
- Redox control of Renal function and hypertension.
- Renin-angiotensin-aldosterone system-mediated redox effects in chronic Kidney disease.
- Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients With overt nephropathy: results from the AMADEO study.
- Dual renin-angiotensin system blockade in the ONTARGET study: clinically relevant risk for the Kidney?
- Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
- Intraperitoneal drug therapy: an advantage.
- Bioabsorbable coronary stents--are these the next big thing in coronary angioplasty?
- Stenting Renal artery stenosis: what is the fuss all about?
- Is there a future for direct renin inhibitors?
- Micro vs. macrovascular reactivity in insulin resistance: the debate reignited.
- The emerging role of biomarkers in diabetic and hypertensive chronic Kidney disease.
- Resistant Hypertension in the high-risk metabolic patient.
- Chronic Kidney disease as a cardiovascular risk state and considerations for the use of statins.
- The importance of early identification of chronic Kidney disease.
- Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin.
- Update on the role of rituximab in Kidney diseases and transplant.
- Mineralocorticoid receptor-dependent proximal tubule injury is mediated by a redox-sensitive mTOR/S6K1 pathway.
- The Role of Tissue Renin-Angiotensin-Aldosterone System in the Development of Endothelial Dysfunction and Arterial Stiffness.
Schools
Grant Medical College Maharashtra University Of Health Sciences
University Of Missouri Hospital and Clinics
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Calcium Metabolism Disorders
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
University of Missouri-Columbia -
Grant Medical College
Drug Facts
| NPI NUMBER | 1558464776 | |
| NPPES Provider LastName | NISTALA | |
| NPPES Provider FirstName | RAVI | |
| NPPES Provider ZIPCode | 65212 | |
| NPPES Provider State | MO | |
| Specialty Description | Nephrology | |
| Total Claim Count | 269.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 4.46 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1558464776 |
| Last Name Of The Provider | NISTALA |
| First Name Of The Provider | RAVI |
| View All |
Similar Doctors
|
|
Dr. Garry P. Reams, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Blake J. Brooks, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua S. Botdorf, DO |
|
|
Dr. Venkatesh K. Ariyamuthu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Smrita Dorairajan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Preethi Yerram, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prasad B. Bichu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Madhukar Misra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prashant R. Kolar, MD |
|
|
Dr. C S. Brooks, MD |
|
|
Dr. Zbylut J. Twardowski, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. James Nanson, MD |